What to make of the healthcare investment landscape in 2023

Not as dire as some would tell you, but a ton more scrutiny just about everywhere. If you’re a keen observer of where the smart money is going in healthcare, you might be a bit perplexed lately. 

Christopher Kerns
Christopher Kerns
Updated Jul 19, 2024 7 min read

Not as dire as some would tell you, but a ton more scrutiny just about everywhere

If you’re a keen observer of where the smart money is going in healthcare, you might be a bit perplexed lately. Last year saw a record number of deals, but velocity dropped off sharply at the end of the year, and valuations are down from their peaks. So what are we to make of these developments? After a pandemic and a huge amount of cash poured into the healthcare ecosystem, trends are starting to look ominous.

To help us make sense of it, a couple of weeks ago I hosted a panel of investment experts at the Healthcare Summit at Jackson Hole, an annual event convening pioneers, innovators, and investors from across the industry. Our experts all came with different vantage points in the finance world—venture capital, investment banks, private equity, and even a not-for-profit health system. The panel comprised Andy Colbert, Senior Managing Director at Ziegler; Steve Rodgers, Managing Director at Morgan Stanley Capital Partners; George Sauter, Chief Strategy Officer at John Muir Health; and Brad Sloan, Managing Partner at Questa Capital. So what did we learn? I’ll start with some observations about what’s actually happening in the current market, and then follow up with four conclusions about how investment activity is likely to trend across the next 12 months.

Let’s talk.

Questions? Want to learn more about what Union can do for you? We’d love to hear from you.